Tough Riley H, McLaren Paul J
JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, MB, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
Front Genet. 2019 Jan 23;9:720. doi: 10.3389/fgene.2018.00720. eCollection 2018.
The course of Human Immunodeficiency Virus type 1 (HIV) infection is a dynamic interplay in which both host and viral genetic variation, among other factors, influence disease susceptibility and rate of progression. HIV set-point viral load (spVL), a key indicator of HIV disease progression, has an estimated 30% of variance attributable to common heritable effects and roughly 70% attributable to environmental factors and/or additional non-genetic factors. Genome-wide genotyping and sequencing studies have allowed for large-scale association testing studying host and viral genetic variants associated with infection and disease progression. Host genomics of HIV infection has been studied predominantly in Caucasian populations consistently identifying human leukocyte antigen (HLA) genes and C-C motif chemokine receptor 5 as key factors of HIV susceptibility and progression. However, these studies don't fully assess all classes of genetic variation (e.g., very rare polymorphisms, copy number variants etc.) and do not inform on non-European ancestry groups. Additionally, viral sequence variability has been demonstrated to influence disease progression independently of host genetic variation. Viral sequence variation can be attributed to the rapid evolution of the virus within the host due to the selective pressure of the host immune response. As the host immune system responds to the virus, e.g., through recognition of HIV antigens, the virus is able to mitigate this response by evolving HLA-specific escape mutations. Diversity of viral genotypes has also been correlated with moderate to strong effects on CD4+ T cell decline and some studies showing weak to no correlation with spVL. There is evidence to support these viral genetic factors being heritable between individuals and the evolution of these factors having important consequences in the genetic epidemiology of HIV infection on a population level. This review will discuss the host-pathogen interaction of HIV infection, explore the importance of host and viral genetics for a better understanding of pathogenesis and identify opportunities for additional genetic studies.
1型人类免疫缺陷病毒(HIV)感染的病程是一种动态相互作用,其中宿主和病毒的基因变异等多种因素会影响疾病易感性和进展速度。HIV设定点病毒载量(spVL)是HIV疾病进展的关键指标,估计约30%的变异归因于常见的遗传效应,约70%归因于环境因素和/或其他非遗传因素。全基因组基因分型和测序研究使得大规模关联测试得以开展,以研究与感染和疾病进展相关的宿主和病毒基因变异。HIV感染的宿主基因组学主要在白种人群中进行研究,一致确定人类白细胞抗原(HLA)基因和C-C基序趋化因子受体5是HIV易感性和进展的关键因素。然而,这些研究并未充分评估所有类型的基因变异(例如,非常罕见的多态性、拷贝数变异等),也未涉及非欧洲血统群体。此外,已证明病毒序列变异性可独立于宿主基因变异影响疾病进展。病毒序列变异可归因于病毒在宿主体内由于宿主免疫反应的选择压力而快速进化。当宿主免疫系统对病毒作出反应时,例如通过识别HIV抗原,病毒能够通过进化出HLA特异性逃逸突变来减轻这种反应。病毒基因型的多样性也与对CD4+T细胞减少的中度至强烈影响相关,一些研究表明与spVL的相关性较弱或无相关性。有证据支持这些病毒遗传因素在个体间具有遗传性,并且这些因素的进化在HIV感染的群体水平遗传流行病学中具有重要影响。本综述将讨论HIV感染的宿主-病原体相互作用,探讨宿主和病毒遗传学对于更好理解发病机制的重要性,并确定进一步开展基因研究的机会。